Silverfin false false 31/12/2024 01/12/2023 31/12/2024 A D M Leeper 01/12/2023 O B Leeper 01/12/2023 29 August 2025 no description of principal activity 15321583 2024-12-31 15321583 bus:Director1 2024-12-31 15321583 bus:Director2 2024-12-31 15321583 core:CurrentFinancialInstruments 2024-12-31 15321583 core:ShareCapital 2024-12-31 15321583 core:RetainedEarningsAccumulatedLosses 2024-12-31 15321583 core:OfficeEquipment 2023-11-30 15321583 2023-11-30 15321583 core:OfficeEquipment 2024-12-31 15321583 bus:OrdinaryShareClass1 2024-12-31 15321583 2023-12-01 2024-12-31 15321583 bus:FilletedAccounts 2023-12-01 2024-12-31 15321583 bus:SmallEntities 2023-12-01 2024-12-31 15321583 bus:AuditExemptWithAccountantsReport 2023-12-01 2024-12-31 15321583 bus:PrivateLimitedCompanyLtd 2023-12-01 2024-12-31 15321583 bus:Director1 2023-12-01 2024-12-31 15321583 bus:Director2 2023-12-01 2024-12-31 15321583 core:OfficeEquipment core:TopRangeValue 2023-12-01 2024-12-31 15321583 core:OfficeEquipment 2023-12-01 2024-12-31 15321583 bus:OrdinaryShareClass1 2023-12-01 2024-12-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 15321583 (England and Wales)

APOLLO HEALTH & MEDICAL LIMITED

Unaudited Financial Statements
For the financial period from 01 December 2023 to 31 December 2024
Pages for filing with the registrar

APOLLO HEALTH & MEDICAL LIMITED

Unaudited Financial Statements

For the financial period from 01 December 2023 to 31 December 2024

Contents

APOLLO HEALTH & MEDICAL LIMITED

STATEMENT OF FINANCIAL POSITION

As at 31 December 2024
APOLLO HEALTH & MEDICAL LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 December 2024
Note 31.12.2024
£
Fixed assets
Tangible assets 3 515
515
Current assets
Debtors 4 ( 1,169)
Cash at bank and in hand 5 5,216
4,047
Creditors: amounts falling due within one year 6 ( 2,616)
Net current assets 1,431
Total assets less current liabilities 1,946
Net assets 1,946
Capital and reserves
Called-up share capital 7 2
Profit and loss account 1,944
Total shareholders' funds 1,946

For the financial period ending 31 December 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Apollo Health & Medical Limited (registered number: 15321583) were approved and authorised for issue by the Board of Directors. They were signed on its behalf by:

A D M Leeper
Director

29 August 2025

APOLLO HEALTH & MEDICAL LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 01 December 2023 to 31 December 2024
APOLLO HEALTH & MEDICAL LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 01 December 2023 to 31 December 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

General information and basis of accounting

Apollo Health & Medical Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is C/O Larking Gowen Prospect House, Rouen Road, Norwich, NR1 1RE, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the supply of services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the fair value of the consideration received or receivable. Where a contract has only been partially completed at the Statement of Financial Position date turnover represents the fair value of the service provided to date based on the stage of completion of the contract activity at the Statement of Financial Position date. Where payments are received from customers in advance of services provided, the amounts are recorded as deferred income and included as part of creditors due within one year.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Office equipment 3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

2. Employees

Period from
01.12.2023 to
31.12.2024
Number
Monthly average number of persons employed by the Company during the period, including directors 2

3. Tangible assets

Office equipment Total
£ £
Cost
At 01 December 2023 0 0
Additions 741 741
At 31 December 2024 741 741
Accumulated depreciation
At 01 December 2023 0 0
Charge for the financial period 226 226
At 31 December 2024 226 226
Net book value
At 31 December 2024 515 515

4. Debtors

31.12.2024
£
Amounts owed by directors ( 1,169)

5. Cash and cash equivalents

31.12.2024
£
Cash at bank and in hand 5,216

6. Creditors: amounts falling due within one year

31.12.2024
£
Accruals 1,800
Taxation and social security 816
2,616

7. Called-up share capital

31.12.2024
£
Allotted, called-up and fully-paid
2 Ordinary shares of £ 1.00 each 2